SCHEMBL5705642

SCHEMBL5705642

COc1cc(C(OCCC[As](C)C)c2nccn2C)cc(OC)c1OC

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.34
ALDH1A1 P00352 2/20 0.34
KMT2A Q03164 2/20 0.33
MEN1 O00255 1/20 0.33
FGB P02675 1/20 0.33
ALOX15 P16050 1/20 0.33
TNNI3 P19429 1/20 0.33
MAPK1 P28482 1/20 0.33
CASP1 P29466 1/20 0.33
BRCA1 P38398 1/20 0.33
TNNT2 P45379 1/20 0.33
CASP7 P55210 1/20 0.33
TNNC1 P63316 1/20 0.33
KEAP1 Q14145 1/20 0.33
NFE2L2 Q16236 1/20 0.33
HSD17B10 Q99714 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.32
TSHR P16473 1/20 0.31
MAPT P10636 1/20 0.31
TUBB1 Q9H4B7 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4907880 0.84 FYN (0.37) SMN1; SMN2ALDH1A1KMT2AMEN1FGB
SCHEMBL4899064 0.72 KDM4E (0.55) SMN1; SMN2ALDH1A1KMT2AMEN1FGB
SCHEMBL5599264 0.71 KDM4E (0.41) SMN1; SMN2ALDH1A1KMT2AMEN1FGB
SCHEMBL5600123 0.68 MAPT (0.34) SMN1; SMN2ALDH1A1KMT2ATSHRMAPT
SCHEMBL4908334 0.66 L3MBTL1 (0.45) SMN1; SMN2ALDH1A1KMT2AMEN1MAPK1
SCHEMBL501770 0.66 L3MBTL1 (0.40) SMN1; SMN2ALDH1A1KMT2AALOX15MAPK1
SCHEMBL4908743 0.63 MAPT (0.51) SMN1; SMN2ALDH1A1KMT2AL3MBTL1TSHR
SCHEMBL4899031 0.62 L3MBTL1 (0.39) L3MBTL1MAPTFFAR1KDM4E
SCHEMBL4910626 0.62 HRH3 (0.51) SMN1; SMN2MAPK1L3MBTL1TSHRMAPT
SCHEMBL4908660 0.61 KDM4E (0.42) SMN1; SMN2MAPK1L3MBTL1TSHRMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1695704-A1 Derivatives of aryl (or heteroaryl) azolylcarbinols for the treatment of fibromyalgia LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2006-08-30 EP disclosed